PMC · DOI:10.1093/ehjcvp/pvaf038·May 21, 2025
SGLT-2 inhibitors in cancer patients with diabetes: when cardioprotection is key
Mattia Brambilla, Bianca Larroux, Aldo Bonaventura
Abstract
Linked entities
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Species1
Figures1
Click any figure to enlarge with its caption.
Figure 1Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsDiabetes Treatment and Management · Chemotherapy-induced cardiotoxicity and mitigation · Metabolism, Diabetes, and Cancer